Pfizer Spinoff Cerevel to Merge with Another Company to Raise $445 Million Funds

The Boston-based biotech firm, Cerevel Therapeutics, which spun out of Pfizer in 2018 has announced that it will go into a merger with another company, and also go public.The merger deal was announced...